107.522 articles found

Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

Kim JH, Auerbach JM, Rodríguez-Gómez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sánchez-Pernaute R, Bankiewicz K, McKay R.

Nature · 2002-06-20

DOI: 10.1038/nature00900PMID: 12077607

Microemulsions for the transdermal administration of apomorphine, for the treatment of Parkinson's disease

Gasco Maria Rosa.

· 2002-06-19

Topographical alterations of the midbrain and the substantia nigra following unilateral posteroventral pallidotomy in patients with Parkinson's disease using routine and multishot diffusion-weighted magnetic resonance imaging.

Adachi M, Kurimura M, Saito S, Hosoya T, Kayama T, Kato T.

Neuroradiology · 2002-06-19

DOI: 10.1007/s00234-002-0744-8PMID: 12136359

Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.

Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T, Parkinson Study Group.

Am J Hum Genet · 2002-06-07

DOI: 10.1086/341282PMID: 12058349

Phenylethanolamine N-methyltransferase has beta-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson's disease.

Gearhart DA, Neafsey EJ, Collins MA.

Neurochem Int · 2002-06-01

DOI: 10.1016/s0197-0186(01)00115-2PMID: 11900856

Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.

Gouhier C, Chalon S, Aubert-Pouessel A, Venier-Julienne MC, Jollivet C, Benoit JP, Guilloteau D.

Synapse · 2002-06-01

DOI: 10.1002/syn.10063PMID: 11954043

Neural rhythms in Parkinson's disease.

Farmer S.

Brain · 2002-06-01

DOI: 10.1093/brain/awf144PMID: 12023308

Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease.

Levy R, Ashby P, Hutchison WD, Lang AE, Lozano AM, Dostrovsky JO.

Brain · 2002-06-01

DOI: 10.1093/brain/awf128PMID: 12023310

Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study.

Ito K, Nagano-Saito A, Kato T, Arahata Y, Nakamura A, Kawasumi Y, Hatano K, Abe Y, Yamada T, Kachi T, Brooks DJ.

Brain · 2002-06-01

DOI: 10.1093/brain/awf134PMID: 12023324

Behavioural disorders, Parkinson's disease, and subthalamic stimulation.

Brown RG.

J Neurol Neurosurg Psychiatry · 2002-06-01

DOI: 10.1136/jnnp.72.6.689PMID: 12023406

Behavioural disorders, Parkinson's disease and subthalamic stimulation.

Houeto JL, Mesnage V, Mallet L, Pillon B, Gargiulo M, du Moncel ST, Bonnet AM, Pidoux B, Dormont D, Cornu P, Agid Y.

J Neurol Neurosurg Psychiatry · 2002-06-01

DOI: 10.1136/jnnp.72.6.701PMID: 12023409

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study.

Aarsland D, Laake K, Larsen JP, Janvin C.

J Neurol Neurosurg Psychiatry · 2002-06-01

DOI: 10.1136/jnnp.72.6.708PMID: 12023410